Display options
Share it on

J Clin Endocrinol Metab. 2010 Nov;95(11):4985-92. doi: 10.1210/jc.2010-0143. Epub 2010 Aug 25.

DHEA-S levels and cardiovascular disease mortality in postmenopausal women: results from the National Institutes of Health--National Heart, Lung, and Blood Institute (NHLBI)-sponsored Women's Ischemia Syndrome Evaluation (WISE).

The Journal of clinical endocrinology and metabolism

Chrisandra Shufelt, Philip Bretsky, Cristina M Almeida, B Delia Johnson, Leslee J Shaw, Ricardo Azziz, Glenn D Braunstein, Carl J Pepine, Vera Bittner, Diane A Vido, Frank Z Stanczyk, C Noel Bairey Merz

Affiliations

  1. Heart Institute, Cedars-Sinai Medical Center, Los Angeles, California 90048, USA.

PMID: 20739385 PMCID: PMC2968728 DOI: 10.1210/jc.2010-0143

Abstract

CONTEXT: Dehydroepiandrosterone sulfate (DHEA-S), a major circulating sex steroid prohormone, declines with age. Low levels have been associated with increased cardiovascular disease (CVD) risk and all-cause mortality, although these results have not been consistently replicated, particularly in women.

OBJECTIVE: Our objective was to examine the association of circulating DHEA-S levels, CVD, and mortality risk among postmenopausal women with suspected myocardial ischemia.

DESIGN: In the Women's Ischemia Syndrome Evaluation, 270 postmenopausal women underwent coronary angiography and blood hormone levels for suspected ischemia and were followed annually. The primary outcome of interest was CVD mortality; secondary analyses included all-cause mortality and nonfatal CVD events (myocardial infarction, stroke, and congestive heart failure) and angiographic obstructive coronary artery disease (CAD).

RESULTS: Women in the lowest DHEA-S tertile had higher CVD mortality (17% 6-yr mortality rate vs. 8%; log-rank P = 0.011), and all-cause mortality (21 vs. 10%; P = 0.011) compared with women with higher DHEA-S levels. The increased CVD mortality risk [hazard ratio (HR) = 2.55; 95% confidence interval (CI) = 1.19-5.45] remained unchanged after adjustment for multiple CVD risk factors (HR = 2.43; 95% CI = 1.06-5.56) but became nonsignificant when further adjusting for the presence or severity of angiographic obstructive CAD (HR = 1.99; 95% CI = 0.87-4.59). Results were similar for all-cause mortality. Lower DHEA-S levels were only marginally but not independently associated with obstructive CAD.

CONCLUSIONS: Among postmenopausal women with coronary risk factors undergoing coronary angiography for suspected myocardial ischemia, lower DHEA-S levels were linked with higher CVD mortality and all-cause mortality. Our study provides valuable feasibility data useful for future investigations and possible mechanistic pathways.

References

  1. J Clin Endocrinol Metab. 1999 Jun;84(6):2008-12 - PubMed
  2. Menopause. 2001 Jan-Feb;8(1):43-50 - PubMed
  3. J Gerontol A Biol Sci Med Sci. 2006 Sep;61(9):957-62 - PubMed
  4. J Am Coll Cardiol. 1999 May;33(6):1453-61 - PubMed
  5. J Clin Endocrinol Metab. 1994 Nov;79(5):1273-6 - PubMed
  6. J Gerontol A Biol Sci Med Sci. 2009 Dec;64(12):1268-74 - PubMed
  7. J Clin Endocrinol Metab. 1984 Sep;59(3):551-5 - PubMed
  8. J Lab Clin Med. 1998 Apr;131(4):316-23 - PubMed
  9. Fertil Steril. 2006 Aug;86(2):484-6 - PubMed
  10. J Clin Endocrinol Metab. 1997 Aug;82(8):2396-402 - PubMed
  11. J Clin Endocrinol Metab. 2004 Jul;89(7):3449-54 - PubMed
  12. Ann N Y Acad Sci. 1995 Dec 29;774:271-80 - PubMed
  13. Aging (Milano). 1999 Feb;11(1):30-4 - PubMed
  14. J Clin Epidemiol. 1999 Feb;52(2):95-103 - PubMed
  15. Acta Cardiol. 2003 Oct;58(5):403-10 - PubMed
  16. J Clin Endocrinol Metab. 2001 Sep;86(9):4171-7 - PubMed
  17. Menopause. 2009 Mar-Apr;16(2):272-8 - PubMed
  18. Circulation. 1992 Nov;86(5):1529-35 - PubMed
  19. N Engl J Med. 1986 Dec 11;315(24):1519-24 - PubMed
  20. Fertil Steril. 2001 Oct;76(4):823-5 - PubMed
  21. Am J Cardiol. 2001 Apr 15;87(8):937-41; A3 - PubMed
  22. Gerontology. 1995;41(6):343-51 - PubMed
  23. J Clin Endocrinol Metab. 2004 Nov;89(11):5558-62 - PubMed
  24. Eur J Endocrinol. 2004 Dec;151(6):717-25 - PubMed
  25. Clin Endocrinol (Oxf). 2005 Jun;62(6):644-9 - PubMed
  26. Clin Chem. 1986 Jan;32(1 Pt 1):146-52 - PubMed
  27. Circulation. 1995 Mar 15;91(6):1757-60 - PubMed
  28. Am J Epidemiol. 2002 Mar 1;155(5):437-45 - PubMed
  29. J Am Coll Cardiol. 1990 Nov;16(6):862-70 - PubMed
  30. Endocr Regul. 1998 Dec;32(4):169-176 - PubMed
  31. J Womens Health (Larchmt). 2004 Oct;13(8):872-87 - PubMed
  32. Fertil Steril. 1991 Sep;56(3):427-33 - PubMed
  33. Eur J Endocrinol. 2001 Jul;145(1):1-9 - PubMed
  34. J Clin Endocrinol Metab. 1990 May;70(5):1273-9 - PubMed
  35. J Clin Endocrinol Metab. 2008 Apr;93(4):1276-84 - PubMed
  36. Diabetologia. 1985 Jul;28(7):412-9 - PubMed

Substances

MeSH terms

Publication Types

Grant support